P53 R282W p53 gene mutation
Variables +ve case - ve case Chi-Square df P value
Males 50(62.5%) 30(37.5%) 0.0027 1 0.95
Females 12(60%) 8(40%)      
Age group
<45 11(84.61%) 2(15.38%) 2.2343 1 0.134
>45 51(58.62%) 36(41.37%)      
Stage of the disease
Early Stage ( I & II ) 15(42.85%) 20(57.14%) 7.1718 1 0.007
Advanced Stage (III & IV ) 47(72.30%) 18(27.69%)      
Smoking status
Non Smoker 17(56.66%) 13(43.33%) 0.24 1 0.6242
Smokers 45(64.28%) 25(35.72)      
Current Smoker 23(82.14%) 5(17.85%) 5.25 1 0.02
Ex Smoker 22(52.38%) 20(47.61%)      
Smoking level ( pack year )
Mild (<10) 6(85.71%) 1(14.28%) 1.61 2 0.4471
Moderate (< 40) 20(60.60%) 13(39.39%)      
Heavy (> 40) 19(63.33%) 11(36.66%)      
Histological type
ADC 35(76.08%) 11(23.91%) 6.1105 1 0.0134
SCC 27(50%) 27(50%)      
Cytological type (ADC)
Well Differentiated 6(77.77%) 3(22.22%) 0.66 2 0.7189
Moderately Differentiated 9(75%) 3(25%)      
Poorly Differentiated 20(80%) 5(20%)      
Cytological type(SCC)
Well Differentiated 14(46.66%) 16(53.33%) 2.8 2 0.2466
Moderately Differentiated 10(66.66%) 5(33.33%)      
Poorly Differentiated 3(33.33%) 6(66.66%)      
Metastasis
Positive 23(85.18%) 4(14.81%) 7.1447 1 0.0075
Negative 39(53.42%) 34(46.57%)      
Family history of any cancer
Significant (Positive) 11(61.11%) 7(38.88%) 0.0332 1 0.8553
Non Significant (Negative) 51(62.19%) 31(37.80%)      
Table 3: Clinicopathological feature of NSCLC patients.